News

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), today announced that its CEO and Chairman ...
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the ...
Lucid Diagnostics' EsoGuard test may soon gain Medicare coverage, boosting its market potential. Read more here.
AppLovin Corporation (NASDAQ:APP) is one of the best multibagger stocks according to hedge funds. On July 23, 2025, BTIG ...
Detailed price information for Rithm Capital Corp (RITM-N) from The Globe and Mail including charting and trades.
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...
BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence ("AI") and machine learning to enable the ...
The stock market may soon face a pullback based on technical indicators, according to Jonathan Krinsky, managing director and chief market technician at BTIG. The S&P 500 is on track to close above ...
NRx Pharmaceuticals (NASDAQ: NRXP) , announced that CEO and Chairman Prof. Jonathan Javitt, MD, MPH will participate in a fireside chat at the BTIG V ...
Fintel reports that on July 23, 2025, BTIG downgraded their outlook for Unity Software (NYSE:U) from Neutral to Sell. Analyst ...
NRx Pharmaceuticals (NASDAQ: NRXP), announced that CEO and Chairman Prof. Jonathan Javitt, MD, MPH will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on July 29–30, 2025.